Also listed on Aclaris Therapeutics, Inc., an earlier holder on the record. The recorded assignments below show how it moved.
Term ends Oct 13, 2029 · High confidence
20-year base term ends Nov 17, 2028
Held by Epi Health, LLC
Filed Nov 17, 2008 as application 12/272,253 · Granted Feb 14, 2012
Base term plus 330 days of patent term adjustment (USPTO delay)
Today
2008
2029
Clock starts
Nov 17, 2008
Nov 17, 2008
Term ends
Oct 13, 2029
Oct 13, 2029
Granted
Feb 14, 2012
Feb 14, 2012
base term
patent term adjustment
fee events
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
330
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
4
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 330 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Nov 17, 2008, when this application, 12/272,253, was filed | Nov 17, 2028 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +330 days, USPTO patent term adjustment record | Oct 13, 2029 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Oct 13, 2029 | High confidence |
This family
| US 8,114,898 | this patent Oct 2029 | Oct 2029 |
| US 8,673,953 | Lapsed on the fee record Mar 2026 | Mar 2026 |
| US 9,265,761 | In force Nov 2028 | Nov 2028 |
| Application 14/505,100 | Abandoned not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Jan 23, 2009 Reel 22149, frame 338 | Shanler, Stuart D.; Ondo, Andrew | Aspect Pharmaceuticals, LLC | Assignment of Assignor's Interest |
| Oct 22, 2009 Reel 23408, frame 935 | Aspect Pharmaceuticals, LLC | Vicept Therapeutics, Inc. | Assignment of Assignor's Interest |
| Nov 30, 2011 Reel 27302, frame 782 | Vicept Therapeutics, Inc. | Allergan, Inc. | Assignment of Assignor's Interest |
| Dec 5, 2018 Reel 47681, frame 466 | Allergan, Inc. | Aclaris Therapeutics, Inc. | Assignment of Assignor's Interest |
| Nov 1, 2019 Reel 50905, frame 290 | Aclaris Therapeutics, Inc. | Epi Health, LLC | Assignment of Assignor's Interest |
| Mar 14, 2022 Reel 59364, frame 509 | Epi Health, LLC | Evening Post Group, LLC | Security Interest |
| Jan 11, 2023 Reel 62347, frame 129 | Evening Post Group, LLC | Epi Health, LLC | Release of Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
Oct 2029
Term ends Oct 13, 2029. No further fees fall due before then
Note
The 330 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
43
later US patents cite this one
That is top 25% of utility patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.